Sangamo Therapeutics (SGMOQ) Amortizatization of Intangibles (2010 - 2025)
Sangamo Therapeutics (SGMOQ) posted Amortizatization of Intangibles of $924000.0 for Q4 2025, up 1.65% on a QoQ basis from $909000.0 in Q3 2025, and up 3.36% year-over-year from $894000.0 in Q4 2024.
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Amortizatization of Intangibles (2010 - 2025) Analysis & Trends
Sangamo Therapeutics has reported Amortizatization of Intangibles for 16 years, with the latest figure at $924000.0 in Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles rose 3.36% year-over-year to $924000.0 in Q4 2025; TTM through Dec 2025 was $3.6 million, a 14.41% decrease from a year earlier, with the FY2025 full-year figure at $3.6 million, down 14.41% from the prior year.
- Amortizatization of Intangibles was $924000.0 for Q4 2025 at Sangamo Therapeutics, up from $909000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $10.6 million in Q4 2021, with the low at -$909000.0 in Q2 2021.
- Average Amortizatization of Intangibles over 5 years is $1.6 million, with a median of $916500.0 recorded in 2024.
- The sharpest annual moves came in 2021 and 2023: Amortizatization of Intangibles slumped 433.84% in 2021, then jumped 4579.07% in 2023.
- Over 5 years, Amortizatization of Intangibles stood at $10.6 million in 2021, then tumbled by 80.2% to $2.1 million in 2022, then slumped by 43.63% to $1.2 million in 2023, then fell by 24.37% to $894000.0 in 2024, then gained by 3.36% to $924000.0 in 2025.
- The last three Amortizatization of Intangibles figures came in at $924000.0 (Q4 2025), $909000.0 (Q3 2025), and $904000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 210,000.00 |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | 902,000.00 |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 7.70 Mn |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | -3.57 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | 64,000.00 |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 208,000.00 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -905,000.00 |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 1.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | 924,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | 909,000.00 |
| Jun 30, 2025 | 904,000.00 |
| Mar 31, 2025 | 904,000.00 |
| Dec 31, 2024 | 894,000.00 |
| Sep 30, 2024 | 909,000.00 |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.93 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 2.09 Mn |
| Dec 31, 2022 | 2.10 Mn |
| Sep 30, 2022 | 6.56 Mn |
| Jun 30, 2022 | -43,000.00 |
| Mar 31, 2022 | -164,000.00 |
| Dec 31, 2021 | 10.59 Mn |
| Sep 30, 2021 | -661,000.00 |
| Jun 30, 2021 | -909,000.00 |
| Mar 31, 2021 | -824,000.00 |